Suono Bio is working to revolutionize what therapeutics may be used to treat diseases.
Advances in genomics have enabled a step-shift in our understanding of diseases and relevant targets to treat those diseases, but delivery technologies lag. Suono is developing potentially superior therapies, like nucleic acids and gene therapies, in a simplified proprietary formulation. The company aims to enable the use of the right drug at the right location in the right patient.
Enabling the oral delivery of macromolecules: The ultrasound pill
Suono is a spinout from the 2011 project, Enabling the oral delivery of macromolecules: The ultrasound pill.
Enhancing drug delivery with ultrasound
Suono Bio, co-founded by MIT alumnus Carl Schoellhammer and two MIT professors, uses ultrasound waves to deliver drugs to the gastrointestinal tract.